Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Functional Genomic Analysis of Azole Antifungal Resistance in the Fungal Pathogen Candida albicans

FY 2016-17

Summary
Fungal pathogens pose an emerging threat to public health worldwide. Treatment of these pathogens is often difficult, and costly. Fungal pathogens kill more humans than malaria or tuberculosis annually. A leading fungal pathogen of humans, Candida albicans, can cause deadly bloodstream infections, especially in the immunocompromised. Treatment options are limited due to the molecular conservation shared between this eukaryotic pathogen and humans. The most widely prescribed class of antifungals, the azoles, target biosynthesis of a key membrane sterol, inhibiting fungal growth. Fungal pathogens can rapidly evolve resistance to azoles during clinical treatments. Characterization of resistance mechanisms can enable the identification of novel resistance determinants. By targeting these determinants chemically, the emergence of resistance may be impeded, and antifungal-resistant infections may also be sensitized to azole treatments. My project leverages genetic and chemical screens to identify novel mechanisms of azole resistance. Through genetic screens, I have identified two genes necessary for azole resistance whose role in antifungal drug resistance has yet to be described. Leveraging genetic and biochemical assays, I will uncover the mechanism by which these genes orchestrate azole resistance. I have also screened a chemical library to identify compounds that inhibit the growth of azole-resistant C. albicans and identified eight that potentiate the efficacy of azoles. I will characterize the molecular target of these compounds through chemical genomic approaches. This work is poised to identify novel azole resistance mechanisms, and to reveal new treatment options for this life-threatening infectious disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367255
Name
Mount Harley
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional Genomic Analysis of Azole Antifungal Resistance in the Fungal Pathogen Candida albicans
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antifungals; Azoles; Candida Albicans; Candidiasis; Fungi; Iatrogenic; Immunocompromised; Kinase Inhibitors; Pathogen; Resistance
Abstract
Fungal pathogens pose an emerging threat to public health worldwide. Treatment of these pathogens is often difficult, and costly. Fungal pathogens kill more humans than malaria or tuberculosis annually. A leading fungal pathogen of humans, Candida albicans, can cause deadly bloodstream infections, especially in the immunocompromised. Treatment options are limited due to the molecular conservation shared between this eukaryotic pathogen and humans. The most widely prescribed class of antifungals, the azoles, target biosynthesis of a key membrane sterol, inhibiting fungal growth. Fungal pathogens can rapidly evolve resistance to azoles during clinical treatments. Characterization of resistance mechanisms can enable the identification of novel resistance determinants. By targeting these determinants chemically, the emergence of resistance may be impeded, and antifungal-resistant infections may also be sensitized to azole treatments. My project leverages genetic and chemical screens to identify novel mechanisms of azole resistance. Through genetic screens, I have identified two genes necessary for azole resistance whose role in antifungal drug resistance has yet to be described. Leveraging genetic and biochemical assays, I will uncover the mechanism by which these genes orchestrate azole resistance. I have also screened a chemical library to identify compounds that inhibit the growth of azole-resistant C. albicans and identified eight that potentiate the efficacy of azoles. I will characterize the molecular target of these compounds through chemical genomic approaches. This work is poised to identify novel azole resistance mechanisms, and to reveal new treatment options for this life-threatening infectious disease.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mount, Harley
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~